Skip to main content
Caplight Logo









Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://zskytx.com

Last Round

Series B

Aug 1, 2021

Company Overview

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in August 2021.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a biotechnology company that specializes in the research and development of personalized dendritic cell vaccines for the treatment of malignant solid tumors and other diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Comparables

Compare Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. with similar companies based on industry and business-model similarity.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hengsai Biotechnology
85%
Diakonos Oncology
82%
Northwest Biotherapeutics Inc
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 1, 2021
Series ANov 16, 2020
VC RoundJul 1, 2019
VC RoundSep 1, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Investors

Notable investors and investment history

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. investors
InvestorRounds
HMC VenturesSeries A
北京首都科技发展集团有限公司VC Round
华创资本VC Round
久银控股Series B
Cowin CapitalVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2021

    Raised Series B round with participation from 久银控股.

  • Nov 16, 2020

    Raised Series A led by HMC Ventures.

Book a demo to see all signals

For institutional investors. Book with your work email.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s valuation, stock price, and market status.

Is Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. a public or private company?

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a private company.

What is the current stock price of Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.?

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. worth (valuation)?

Valuation information for Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. is not publicly available.

Can I buy Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. stock?

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s last funding round?

Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s most recent funding round was Series B on August 1, 2021.

Who are the main investors in Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.?

Key investors in Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. include HMC Ventures.

Will Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. IPO soon?

No public IPO plans have been announced for Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd..

How can I track Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Zhongsheng Kangyuan Biotechnology (Beijing) Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Year FoundedN/A
Last FundingAug 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?